|
SE438261B
(sv)
*
|
1981-07-08 |
1985-04-15 |
Draco Ab |
Anvendning i dosinhalator av ett perforerat membran
|
|
SE448277B
(sv)
*
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
|
SE453566B
(sv)
|
1986-03-07 |
1988-02-15 |
Draco Ab |
Anordning vid pulverinhalatorer
|
|
US4739754A
(en)
*
|
1986-05-06 |
1988-04-26 |
Shaner William T |
Suction resistant inhalator
|
|
US4929329A
(en)
*
|
1987-04-27 |
1990-05-29 |
Eg&G, Inc. |
Electrophoresis cassette system with apparatus and method for filling same
|
|
GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
|
AU643435B2
(en)
*
|
1989-04-28 |
1993-11-18 |
Riker Laboratories, Inc. |
Dry powder inhalation device
|
|
US5176132A
(en)
*
|
1989-05-31 |
1993-01-05 |
Fisons Plc |
Medicament inhalation device and formulation
|
|
IT1237118B
(it)
*
|
1989-10-27 |
1993-05-18 |
Miat Spa |
Inalatore multidose per farmaci in polvere.
|
|
US5192548A
(en)
*
|
1990-04-30 |
1993-03-09 |
Riker Laboratoires, Inc. |
Device
|
|
GB9015522D0
(en)
*
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
|
JPH06500717A
(ja)
*
|
1990-09-12 |
1994-01-27 |
ビスガールト，ハンス |
吸入装置
|
|
GB9021433D0
(en)
*
|
1990-10-02 |
1990-11-14 |
Atomic Energy Authority Uk |
Power inhaler
|
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
|
US5304125A
(en)
*
|
1990-10-05 |
1994-04-19 |
The University Of North Carolina |
Apparatus for administering solid particulate aerosols to the lungs
|
|
US5392768A
(en)
*
|
1991-03-05 |
1995-02-28 |
Aradigm |
Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval
|
|
US5404871A
(en)
*
|
1991-03-05 |
1995-04-11 |
Aradigm |
Delivery of aerosol medications for inspiration
|
|
US5394866A
(en)
*
|
1991-03-05 |
1995-03-07 |
Aradigm Corporation |
Automatic aerosol medication delivery system and methods
|
|
US5450336A
(en)
*
|
1991-03-05 |
1995-09-12 |
Aradigm Corporation |
Method for correcting the drift offset of a transducer
|
|
DE69430303T2
(de)
*
|
1991-03-05 |
2002-11-28 |
Aradigm Corp |
Verfahren und vorrichtung zur korrektur eines nullsignals eines drucksensors fur einen durchflussmesser
|
|
DE69122388T2
(de)
*
|
1991-04-15 |
1997-03-27 |
Leiras Oy |
Vorrichtung zum dosieren eines pulverförmigen medikaments für die inhalation
|
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US5327883A
(en)
*
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
FR2676929B1
(fr)
*
|
1991-05-30 |
1994-02-11 |
Aerosols Bouchage Ste Fse |
Inhalateur de poudres.
|
|
JP2780871B2
(ja)
*
|
1991-06-26 |
1998-07-30 |
シェリング・コーポレーション |
粉末薬剤吸入装置
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6119688A
(en)
*
|
1991-08-26 |
2000-09-19 |
3M Innovative Properties Company |
Powder dispenser
|
|
CA2114726A1
(en)
*
|
1991-08-26 |
1993-03-04 |
Ralph Duane Whaley |
Powder dispenser
|
|
DE4208880A1
(de)
*
|
1992-03-19 |
1993-09-23 |
Boehringer Ingelheim Kg |
Separator fuer pulverinhalatoren
|
|
DE69319107T2
(de)
*
|
1992-03-25 |
1999-02-25 |
Tebro S.A., Luxembourg |
Pulverabgabevorrichtung für medizinische inhalationstherapien
|
|
SE9201411D0
(sv)
*
|
1992-05-05 |
1992-05-05 |
Astra Ab |
Dosage inhalator with indicating/interupting means
|
|
WO1993024165A1
(de)
*
|
1992-05-29 |
1993-12-09 |
Ggu Gesellschaft Für Gesundheits- Und Umweltforschung Mbh & Co. Vertriebs Kg |
Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
|
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
|
ES2127837T3
(es)
*
|
1992-10-19 |
1999-05-01 |
Dura Pharma Inc |
Inhalador para polvo seco.
|
|
WO1994011044A2
(en)
|
1992-11-12 |
1994-05-26 |
Minnesota Mining And Manufacturing Company |
Powder inhaler
|
|
DE4239402A1
(de)
*
|
1992-11-24 |
1994-05-26 |
Bayer Ag |
Pulverinhalator
|
|
US6250300B1
(en)
|
1992-12-11 |
2001-06-26 |
Ab Astra |
System for dispensing pharmaceutically active compounds
|
|
SE9203743D0
(sv)
*
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
|
ES2128550T3
(es)
*
|
1992-12-18 |
1999-05-16 |
Schering Corp |
Inhalador para medicamentos en polvo.
|
|
FR2700279B1
(fr)
*
|
1993-01-14 |
1995-03-17 |
Valois |
Dispositif portatif pour projeter des doses d'une substance fluide à l'aide d'un flux d'air comprimé.
|
|
AU684754B2
(en)
*
|
1993-03-03 |
1998-01-08 |
Glaxo Wellcome Inc. |
Dry powder inhalator medicament carrier
|
|
GB9306703D0
(en)
*
|
1993-03-31 |
1993-05-26 |
Fisons Plc |
Inhalation device
|
|
DE4319514C2
(de)
*
|
1993-06-14 |
2003-06-18 |
Sofotec Gmbh & Co Kg |
Pulverinhalator
|
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5506203C1
(en)
*
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
|
DE4400084C2
(de)
*
|
1994-01-04 |
2001-08-02 |
Softec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester in einem Luftstrom fein verteilter Form
|
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
AU124387S
(en)
*
|
1994-03-25 |
1995-08-11 |
Astra Ab |
Training device for an inhaler
|
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
|
DE4415462C1
(de)
*
|
1994-05-03 |
1995-08-31 |
Transcoject Marketing Gmbh |
Inhalator
|
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
|
US5522385A
(en)
*
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
|
US5983956A
(en)
*
|
1994-10-03 |
1999-11-16 |
Astra Aktiebolag |
Formulation for inhalation
|
|
US5980949A
(en)
*
|
1994-10-03 |
1999-11-09 |
Astra Aktiebolag |
Formulation for inhalation
|
|
US5647347A
(en)
*
|
1994-10-21 |
1997-07-15 |
Glaxo Wellcome Inc. |
Medicament carrier for dry powder inhalator
|
|
SE9404439D0
(sv)
*
|
1994-12-21 |
1994-12-21 |
Astra Ab |
Inhalation device
|
|
FI972652L
(fi)
*
|
1994-12-22 |
1997-08-18 |
Astra Ab |
Inhaloitava terapeuttinen valmiste, joka sisältää paratyroidihormonia PTH
|
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
US6932962B1
(en)
|
1994-12-22 |
2005-08-23 |
Astrazeneca Ab |
Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
|
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
|
DE19518810A1
(de)
*
|
1995-05-26 |
1996-11-28 |
Bayer Ag |
Nasal-Applikator
|
|
US5654007A
(en)
*
|
1995-06-07 |
1997-08-05 |
Inhale Therapeutic Systems |
Methods and system for processing dispersible fine powders
|
|
JP3317823B2
(ja)
*
|
1995-08-11 |
2002-08-26 |
株式会社ユニシアジェックス |
投薬器
|
|
SE9503344D0
(sv)
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
|
US5797392C1
(en)
*
|
1996-01-22 |
2001-01-09 |
Direct Haler As |
Inhaler
|
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
|
GB9626263D0
(en)
|
1996-12-18 |
1997-02-05 |
Innovata Biomed Ltd |
Powder inhaler
|
|
SE9700135D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
TW469832U
(en)
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
|
SE9700936D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Inhalation device
|
|
SE9700937D0
(sv)
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler I
|
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
|
US6260549B1
(en)
*
|
1998-06-18 |
2001-07-17 |
Clavius Devices, Inc. |
Breath-activated metered-dose inhaler
|
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
GB9902493D0
(en)
|
1999-02-05 |
1999-03-24 |
Glaxo Group Ltd |
Inhalation device
|
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
|
US6223744B1
(en)
|
1999-03-16 |
2001-05-01 |
Multi-Vet Ltd. |
Wearable aerosol delivery apparatus
|
|
AU772798B2
(en)
|
1999-04-21 |
2004-05-06 |
1355540 Ontario Inc. |
Formulations for detecting asthma
|
|
DE60019920T2
(de)
|
1999-06-05 |
2006-02-23 |
Innovata Biomed Ltd., St. Albans |
Verabreichungsystem für medikamente
|
|
ES2569949T3
(es)
|
1999-06-29 |
2016-05-13 |
Mannkind Corporation |
Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
|
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US7464706B2
(en)
*
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
|
GB9917637D0
(en)
*
|
1999-07-27 |
1999-09-29 |
Co Ordinated Drug Dev |
Improvements in or relating to inhaler devices
|
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
|
ATE296654T1
(de)
*
|
1999-12-07 |
2005-06-15 |
Orion Corp |
Mehrfachpulverinhalator
|
|
US6669960B2
(en)
|
1999-12-21 |
2003-12-30 |
Rxkinetix, Inc. |
Particulate drug-containing products and method of manufacture
|
|
US6761909B1
(en)
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
|
MXPA02008403A
(es)
|
2000-02-28 |
2004-09-27 |
Vectura Ltd |
Mejoras en o relacionadas con el suministro de farmacos por via oral.
|
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
ES2525087T5
(es)
*
|
2000-05-10 |
2018-06-28 |
Novartis Ag |
Polvos basados en fosfolípidos para administración de fármacos
|
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
PL213373B1
(pl)
|
2000-08-05 |
2013-02-28 |
Glaxo Group Ltd |
Ester S-fluorometylowy kwasu 6α,9α-difluoro-17α-(2-furanylokarboksyl)oksy-11β -hydroksy-16α-metylo-3-oksoandrosta-1,4,-dieno-17-karbotiowego, jego zastosowanie, srodek farmaceutyczny, preparat farmaceutyczny, aerozolowy preparat farmaceutyczny, sposób wytwarzania tego estru oraz zwiazki posrednie i sposób ich wytwarzania
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
DE10040528A1
(de)
*
|
2000-08-18 |
2002-02-28 |
Pari Gmbh |
Inhalationsvorrichtung und Verfahren zur Erzeugung eines Partikelnebels für Inhalationszwecke
|
|
DE10047722A1
(de)
*
|
2000-09-27 |
2002-04-11 |
Schuckmann Alfred Von |
Von Saugluftstrom des Benutzers aktivierbare Dosiervorrichtung
|
|
FI20002363A0
(fi)
*
|
2000-10-27 |
2000-10-27 |
Orion Yhtymae Oyj |
Jauheinhalaattori
|
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
|
JP2005504715A
(ja)
|
2000-12-29 |
2005-02-17 |
アドバンスト インハレーション リサーチ，インコーポレイテッド |
持続放出特性を有する吸入用粒子
|
|
DE60221640T2
(de)
*
|
2001-02-06 |
2008-05-21 |
Innovata Biomed Ltd., St. Albans |
Bimodale trockenpulverzusammensetzung zur inhalation
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
|
JP4371660B2
(ja)
*
|
2001-04-26 |
2009-11-25 |
ニユー・イングランド・フアーマシユーテイカルズ・インコーポレイテツド |
液体状および粉末状薬剤のための定量投与デバイス
|
|
PL366937A1
(en)
|
2001-04-30 |
2005-02-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
FI20011317A0
(fi)
*
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
|
DE10129703A1
(de)
|
2001-06-22 |
2003-01-02 |
Sofotec Gmbh & Co Kg |
Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
|
|
JP3619176B2
(ja)
*
|
2001-09-14 |
2005-02-09 |
オムロンヘルスケア株式会社 |
エアロゾル粒子分別装置及び吸入器
|
|
ATE417606T1
(de)
|
2001-09-14 |
2009-01-15 |
Glaxo Group Ltd |
Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
|
|
WO2003024396A2
(en)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Dry powder medicament formulations
|
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
|
EP1455755B1
(en)
*
|
2001-11-20 |
2013-04-17 |
Civitas Therapeutics, Inc. |
Improved particulate compositions for pulmonary delivery
|
|
GB0128148D0
(en)
*
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
|
MXPA04005865A
(es)
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
|
ATE385193T1
(de)
|
2002-03-20 |
2008-02-15 |
Mannkind Corp |
Inhalationsgerät
|
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
|
SE524957C2
(sv)
|
2002-04-12 |
2004-11-02 |
Microdrug Ag |
Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
|
|
SE525027C2
(sv)
*
|
2002-04-12 |
2004-11-16 |
Microdrug Ag |
Anordning utgörande en pulverlufthyvel
|
|
US20030196661A1
(en)
*
|
2002-04-19 |
2003-10-23 |
Miekka Richard George |
Power inhaler employing unit doses of powders in pressurized packages
|
|
AU2003222841A1
(en)
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
|
US6941980B2
(en)
*
|
2002-06-27 |
2005-09-13 |
Nektar Therapeutics |
Apparatus and method for filling a receptacle with powder
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
DE10300032B3
(de)
*
|
2003-01-03 |
2004-05-27 |
E. Braun Gmbh |
Pulverinhalator
|
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
|
WO2004066912A2
(en)
*
|
2003-01-31 |
2004-08-12 |
Technion Research & Development Foundation Ltd. |
Anti-inflammatory compositions and uses thereof
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
|
AU2004240629B2
(en)
*
|
2003-05-16 |
2010-02-25 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
|
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
|
FI20031158A7
(fi)
*
|
2003-08-15 |
2005-02-16 |
Medifiq Healthcare Oy |
Inhalaattori
|
|
CA2538237A1
(en)
*
|
2003-09-10 |
2005-03-24 |
Map Pharmaceuticals, Inc. |
Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
|
|
SE0302665D0
(sv)
*
|
2003-10-07 |
2003-10-07 |
Astrazeneca Ab |
Novel Process
|
|
US7276521B2
(en)
|
2003-10-14 |
2007-10-02 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
|
UY28567A1
(es)
|
2003-10-17 |
2005-05-31 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
|
WO2005044173A1
(en)
*
|
2003-10-27 |
2005-05-19 |
Oriel Therapeutics, Inc. |
Blister packages and associated methods of fabricating dry powder drug containment systems
|
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
|
WO2005053647A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
|
WO2005095407A1
(en)
|
2004-03-17 |
2005-10-13 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
EP1730104A1
(en)
|
2004-04-02 |
2006-12-13 |
Glaxo Group Limited |
Chemical process and new crystalline form
|
|
RU2277940C2
(ru)
*
|
2004-04-16 |
2006-06-20 |
Юрий Васильевич Иванов |
Ингалятор
|
|
BRPI0509348A
(pt)
*
|
2004-04-21 |
2007-09-11 |
Innovata Biomed Ltd |
inalador
|
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
|
MY144753A
(en)
|
2004-04-27 |
2011-10-31 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
|
EP1747219A4
(en)
|
2004-05-13 |
2010-05-26 |
Glaxo Group Ltd |
Antagonists of muscarinic acetylcholine receptor
|
|
RS51206B
(sr)
|
2004-05-31 |
2010-12-31 |
Almirall S.A. |
Kombinacije koje sadrže antimuskarinska sredstva i kortikosteroide
|
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
PL1786784T3
(pl)
|
2004-08-20 |
2011-04-29 |
Mannkind Corp |
Kataliza syntezy diketopiperazyn
|
|
BR122019022692B1
(pt)
|
2004-08-23 |
2023-01-10 |
Mannkind Corporation |
Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
|
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
|
JP5156397B2
(ja)
|
2005-02-10 |
2013-03-06 |
グラクソ グループ リミテッド |
予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤
|
|
AR053346A1
(es)
|
2005-03-25 |
2007-05-02 |
Glaxo Group Ltd |
Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
|
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
|
EP1937068A4
(en)
|
2005-08-18 |
2010-08-04 |
Glaxo Group Ltd |
ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
|
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
|
JP5167133B2
(ja)
|
2005-09-14 |
2013-03-21 |
マンカインド コーポレイション |
結晶性微粒子表面に対する活性薬剤の親和性の増大に基づく薬物処方の方法
|
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
GB2433207B
(en)
|
2006-02-21 |
2009-01-07 |
Jianhe Li |
Active suction actuated inhalers with timing devices
|
|
JP5599975B2
(ja)
|
2006-02-22 |
2014-10-01 |
マンカインド コーポレイション |
ジケトピペラジン及び活性薬剤を含有する微粒子の製剤特性の改善方法
|
|
CA2644679C
(en)
*
|
2006-03-03 |
2013-12-03 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
WO2007121256A2
(en)
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
|
PT103481B
(pt)
*
|
2006-05-16 |
2008-08-01 |
Hovione Farmaciencia S A |
Inalador de uso simples e método de inalação
|
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
|
DK2425820T3
(en)
|
2007-02-11 |
2015-07-13 |
Map Pharmaceuticals Inc |
A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
|
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
|
US20090211576A1
(en)
*
|
2007-10-02 |
2009-08-27 |
Timo Lehtonen |
Safety and abuse deterrent improved device
|
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
CN102036661B
(zh)
|
2008-03-20 |
2016-12-28 |
维尔恩公司 |
维生素衍生物及其用途
|
|
ES2396946T3
(es)
*
|
2008-03-20 |
2013-03-01 |
Virun, Inc. |
Emulsiones que comprenden un derivado de PEG de tocoferol
|
|
PL2254629T3
(pl)
*
|
2008-03-27 |
2016-06-30 |
Mannkind Corp |
Układ inhalatora suchego proszku
|
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
CA3153292A1
(en)
|
2008-06-13 |
2009-12-17 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
|
CN103751892B
(zh)
|
2008-06-20 |
2017-03-01 |
曼金德公司 |
用于对吸入工作进行实时描绘的交互式设备和方法
|
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
CN102405044A
(zh)
*
|
2009-02-06 |
2012-04-04 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
|
EP3578169B1
(en)
|
2009-02-26 |
2024-06-26 |
Glaxo Group Limited |
Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
|
JP5667095B2
(ja)
|
2009-03-11 |
2015-02-12 |
マンカインド コーポレイション |
吸入器の抵抗を測定するための装置、システムおよび方法
|
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
|
MY186975A
(en)
|
2009-06-12 |
2021-08-26 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
|
AU2010260177A1
(en)
|
2009-06-16 |
2011-12-15 |
Merck Sharp & Dohme Corp. |
Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
|
|
SI2453894T1
(sl)
|
2009-07-15 |
2016-02-29 |
Theravance Biopharma R&D Ip, Llc |
Kristalinična oblika proste baze bifenilne spojine
|
|
EP2477642A4
(en)
*
|
2009-09-17 |
2013-03-13 |
Mutual Pharmaceutical Co |
METHOD FOR THE TREATMENT OF ASTHMA WITH ANTIVIRUS AGENTS
|
|
JP5784622B2
(ja)
|
2009-11-03 |
2015-09-24 |
マンカインド コーポレ−ション |
吸入活動をシミュレートするための装置及び方法
|
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
|
AU2010319328A1
(en)
|
2009-11-12 |
2012-05-31 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
WO2011119228A1
(en)
|
2010-03-23 |
2011-09-29 |
Virun, Inc. |
Nanoemulsion including sucrose fatty acid ester
|
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
CN102985125A
(zh)
|
2010-06-21 |
2013-03-20 |
曼金德公司 |
干粉药物输送系统和方法
|
|
US9757528B2
(en)
|
2010-08-23 |
2017-09-12 |
Darren Rubin |
Nebulizer having different negative pressure threshold settings
|
|
CA3071911C
(en)
|
2010-08-23 |
2023-01-17 |
Darren Rubin |
Systems and methods of aerosol delivery with airflow regulation
|
|
EP2883543B1
(en)
|
2010-08-27 |
2016-11-16 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol carbamates
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
AU2011298409B2
(en)
|
2010-08-31 |
2013-11-21 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
EP2954888A1
(en)
|
2010-08-31 |
2015-12-16 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
|
US9297813B2
(en)
|
2010-11-11 |
2016-03-29 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
|
EP2648788B1
(en)
|
2010-12-07 |
2017-08-09 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
EP4374929B1
(en)
|
2010-12-17 |
2025-09-03 |
University of Southern California |
Methods and devices for using isoperillyl alcohol
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
KR101940832B1
(ko)
|
2011-04-01 |
2019-01-21 |
맨카인드 코포레이션 |
의약 카트리지용 블리스터 패키지
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
|
HK1201475A1
(en)
|
2011-10-24 |
2015-09-04 |
Mannkind Corporation |
Methods and compositions for treating pain
|
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
US9421248B2
(en)
|
2011-12-30 |
2016-08-23 |
Grifols, S.A. |
Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
|
|
SG11201404640YA
(en)
|
2012-02-10 |
2014-09-26 |
Virun Inc |
Beverage compositions containing non-polar compounds
|
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
|
WO2013160418A1
(en)
|
2012-04-27 |
2013-10-31 |
Glaxo Group Limited |
Novel compounds
|
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
|
US10370183B2
(en)
|
2012-07-19 |
2019-08-06 |
Adamis Pharmaceuticals Corporation |
Powder feeding apparatus
|
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
EP2925328A1
(en)
|
2012-11-28 |
2015-10-07 |
Intercept Pharmaceuticals, Inc. |
Treatment of pulmonary disease
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
AU2013360866A1
(en)
|
2012-12-18 |
2015-07-02 |
Almirall, S.A. |
New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activity
|
|
AR094797A1
(es)
|
2013-02-15 |
2015-08-26 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
|
JP6523247B2
(ja)
|
2013-03-15 |
2019-05-29 |
マンカインド コーポレイション |
微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
|
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
|
KR102465025B1
(ko)
|
2013-07-18 |
2022-11-09 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
|
WO2015091287A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
|
EP3107606B1
(en)
|
2014-02-21 |
2024-08-28 |
David Brown |
Inhalation device for inhaling powders
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
CN107072976A
(zh)
|
2014-05-12 |
2017-08-18 |
葛兰素史克知识产权第二有限公司 |
用于治疗传染性疾病的包含Danirixin的药物组合物
|
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
EP3244952A4
(en)
|
2015-01-14 |
2018-11-14 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
|
CN107613768B
(zh)
|
2015-02-12 |
2020-10-20 |
NeOnc技术股份有限公司 |
包含紫苏醇衍生物的药物组合物
|
|
JP2018509153A
(ja)
|
2015-03-11 |
2018-04-05 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｔｓｌｐ結合タンパク質
|
|
US10214509B2
(en)
|
2015-04-21 |
2019-02-26 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
|
EP3294390B1
(en)
*
|
2015-05-08 |
2022-10-05 |
Iconovo AB |
Dry powder inhaler
|
|
EP3766878B1
(en)
|
2015-06-15 |
2022-03-16 |
GlaxoSmithKline Intellectual Property Development Limited |
Nrf2 regulators
|
|
US20180179167A1
(en)
|
2015-06-15 |
2018-06-28 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 REGULATORS
|
|
RS61302B1
(sr)
|
2015-06-15 |
2021-02-26 |
Glaxosmithkline Ip Dev Ltd |
Nrf2 regulatori
|
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
|
EP3359532A1
(en)
|
2015-10-06 |
2018-08-15 |
GlaxoSmithKline Intellectual Property Development Limited |
Biaryl pyrazoles as nrf2 regulators
|
|
US10351530B2
(en)
|
2015-10-06 |
2019-07-16 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as NRF2 regulators
|
|
WO2017076990A1
(en)
|
2015-11-05 |
2017-05-11 |
Almirall, S.A. |
Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
|
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產（第二）有限公司 |
Ｔｒｐｖ４拮抗劑
|
|
CA3036933A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
|
ES2992873T3
(en)
|
2016-11-30 |
2024-12-19 |
Univ Southern California |
A perillyl alcohol-3 bromopyruvate conjugate and methods of treating cancer
|
|
WO2018104766A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
|
|
US20200071310A1
(en)
|
2016-12-12 |
2020-03-05 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
|
WO2018109641A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
|
ES2978187T3
(es)
|
2016-12-14 |
2024-09-06 |
Glaxosmithkline Intellectual Property Dev |
Heterociclos de bisarilo como activadores de NRF2
|
|
WO2018109647A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
|
US20220002272A1
(en)
|
2016-12-14 |
2022-01-06 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl lactams as nrf2 activators
|
|
ES2901616T3
(es)
|
2016-12-15 |
2022-03-23 |
Glaxosmithkline Ip Dev Ltd |
Compuestos NRF2
|
|
EP3555082B1
(en)
|
2016-12-15 |
2022-01-26 |
GlaxoSmithKline Intellectual Property Development Limited |
Ether linked triazoles as nrf2 regulators
|
|
EP3599899A1
(en)
|
2017-03-23 |
2020-02-05 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
|
EP3615545B1
(en)
|
2017-04-24 |
2021-09-01 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Ｎｒｆ２路徑的新穎化合物
|
|
CA3096576A1
(en)
|
2017-09-28 |
2019-04-04 |
Iconovo Ab |
A dry powder inhaler with means for enhancing dispersion
|
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
WO2019116230A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CN117069728B
(zh)
|
2018-01-17 |
2025-08-29 |
葛兰素史克知识产权开发有限公司 |
PI4KIIIβ抑制剂
|
|
US20210228498A1
(en)
|
2018-02-08 |
2021-07-29 |
Neonc Technologies, Inc. |
Methods of permeabilizing the blood brain barrier
|
|
WO2019224667A1
(en)
|
2018-05-23 |
2019-11-28 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as nrf2 activators
|
|
TWI821343B
(zh)
|
2018-07-27 |
2023-11-11 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
EP3849978B1
(en)
|
2018-09-10 |
2022-11-02 |
Cocrystal Pharma, Inc. |
Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
|
|
KR102620705B1
(ko)
|
2018-10-11 |
2024-01-04 |
삼성전자주식회사 |
전자 장치 및 그의 동작 방법
|
|
CA3115823A1
(en)
|
2018-10-17 |
2020-04-23 |
Cocrystal Pharma, Inc. |
Combinations of inhibitors of influenza virus replication
|
|
EA202191327A1
(ru)
|
2018-11-13 |
2021-08-09 |
Кокристал Фарма, Инк. |
Лекарственные формы терапевтических препаратов от гриппа
|
|
US20220048897A1
(en)
|
2018-11-26 |
2022-02-17 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
|
CA3123725A1
(en)
*
|
2019-02-15 |
2020-08-20 |
Iconovo Ab |
Inhaler
|
|
AU2019434478A1
(en)
|
2019-03-14 |
2021-09-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders
|
|
CN113840615A
(zh)
|
2019-03-14 |
2021-12-24 |
Om药物公司 |
制备稳定细菌提取物的方法及其作为药物的用途
|
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
|
KR20230008079A
(ko)
|
2020-04-10 |
2023-01-13 |
코크리스탈 파마, 아이엔씨. |
노로바이러스 및 코로나바이러스 복제 억제제
|
|
EP4138884A1
(en)
|
2020-04-20 |
2023-03-01 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
|
CA3227602A1
(en)
|
2021-08-03 |
2023-02-09 |
Irina C. Jacobson |
Inhibitors for coronaviruses
|
|
WO2023205389A1
(en)
|
2022-04-22 |
2023-10-26 |
Quench Medical Inc. |
Dry powder inhalation delivery of pharmaceuticals
|
|
WO2023232976A1
(en)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
|